Dual immuno-oncology agents as neoadjuvant therapy for patients with resectable non-small cell lung cancer

Transl Lung Cancer Res. 2024 Feb 29;13(2):229-235. doi: 10.21037/tlcr-23-738. Epub 2024 Feb 20.

Authors

Hiroyuki Adachi^{1

2}, Hiroyuki Ito², Takuya Nagashima², Tetsuya Isaka², Aya Saito¹

Affiliations

¹ Department of Surgery, Yokohama City University, Yokohama, Japan.
² Department of Thoracic Surgery, Kanagawa Cancer Center, Yokohama, Japan.

No abstract available

Keywords: Immuno-oncology (IO); neoadjuvant therapy; non-small cell lung cancer (NSCLC); surgery.

Publication types

Editorial
Comment